Join our webinar where we will spotlight the fundamental principles of lung microwave ablation. Speakers will cover its clinical applications and review technical considerations essential for successful procedures.

Why attend:

Our goal is to equip you with the knowledge and skills needed to incorporate lung microwave ablation into your clinical practice effectively. You will have the opportunity to ask questions and engage with our panel of experts during the interactive Q&A session.

Moderator and Speakers:

Agenda:

Technical considerations
Dr. Orsi

Summary and final remarks
Prof. Pereira

Emprint™ HP ablation system with Thermosphere™ technology

Our patented Thermosphere™ technology can help lower the risk of recurrence by achieving large ablation volumes with predictable margins.^1,2 The purpose-built innovation helps eradicate your patients’ non-resectable liver tumours and preserve more of their healthy parenchyma^1,2,3 — because their future depends on both.

Learn more about the Emprint™ HP ablation system with patented Thermosphere™ technology.

References

1. Vogl TJ, Basten LM, Nour-Eldin A, et al. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone. Int J Hyperthermia. 2018;34(4):492–500.
2. Takahashi H, Kahramangil B, Kose E, Berber E. A comparison of microwave thermosphere versus radiofrequency thermal ablation in the treatment of colorectal liver metastases. HPB. 2018 Dec;20(12):1157–1162.7.
3. Based on internal test report #RE00085432, An acute GLP study to evaluate the performance and safety of the Emprint™ SX ablation platform in a porcine model. 2017.

The Emprint™ ablation system is intended for use in percutaneous, laparoscopic and intraoperative coagulation (ablation) of soft tissue, such as lung, kidney and liver, including partial or complete ablation of non-resectable liver tumors. Contraindications: Microwave ablation procedures are not recommended for patients with cardiac pacemaker or other implanted electronic devices. Potential risks have not been evaluated. Microwave ablation procedures are not recommended for pregnant patients. Potential risks to the patient and/or fetus have not been established. Risks include but are not limited to tissue irritation or injury, infection and death. Microwave ablation procedures are not recommended for pregnant patients or those with cardiac pacemakers or other implanted electronic devices. Thermal injury, electric shock and explosion and fire hazards are possible. Please review the additional warning and precautions in the User’s Guide prior to use. Risks: While every attempt has been made to reduce patient and user risks, all surgeries using this device carry some residual risk, even when used by trained physicians. Residual risks include: foreign body in patient, foreign body reaction, additional needle stick or puncture delay of treatment, post ablation syndrome, pain, fever, malaise, nausea, vomiting, myalgia, inflammation, hemorrhage, hemoptysis, hematoma, infection, peritonitis, abscess, ascites, seroma, wound dehiscence, adhesions, ischemia, necrosis, urinary retention, emphysema, pleural effusion, pneumothorax, pulmonary or upper respiratory fistula, hemothorax, dyspnea, biliary stenosis, biliary obstruction, biloma, cholangitis, biliary cirrhosis, haemobilia, gastrointestinal fistula, liver dysfunction, hepatic insufficiency, hepatic infarction, jaundice, colonic perforation, renal fistula, embolism, death, atrial fibrillation, tachycardia, cardiomyopathy, arteriovenous fistula and cancer seeding. Important: Always refer to the Instructions For Use (IFU) packaged with the product for complete instructions, indications, contraindications, warnings and precautions.

2024-emprint-hp-webinar-22-oct-2024-email--emea-13486410